Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
sox3xenopus   

Too many results?Too few results?

Experiment details for sox3

Differential distribution of competence for panplacodal and neural crest induction to non-neural and neural ectoderm.

Differential distribution of competence for panplacodal and neural crest induction to non-neural and neural ectoderm.

Gene Clone Species Stages Anatomy
sox3.S laevis NF stage 9 to NF stage 11 animal cap
sox3.S laevis NF stage 12 to NF stage 13 neuroectoderm , pre-chordal neural plate , chordal neural plate , neural plate

Display additional annotations [+]
  Fig. S2. Expression patterns of Dlx3, GATA2 and Sox3. (A) Dlx3 is expressed from stage 9 throughout the animal hemisphere but gradually becomes excluded from prospective neural ectoderm dorsally (asterisks) during gastrulation. (B) GATA2 is expressed from stage 10 in a pattern resembling Dlx3 expression. (C) Sox3 is expressed from stage 9 throughout the animal hemisphere but gradually becomes excluded from prospective non-neural ectoderm ventrally (asterisks) during gastrulation.

Gene Clone Species Stages Anatomy
sox3.S laevis NF stage 18 neural plate

Display additional annotations [+]
  Fig. 7. Dlx3 promotes different non-neural fates depending on the signaling environment. (A-B′) Keratin (A,A′) and Six1 (B,B′) expression in neural plate stage embryos after unilateral injection (lower half; marked by light-blue β-galactosidase staining) of Dlx3 mRNA and treatment with DMSO (A,B) or the BMP signaling antagonist dorsomorphin (A′,B′). Ectopic Keratin expression in the neural plate is strongly reduced, while ectopic Six1 expression is strongly enhanced by dorsomorphin treatment (inset in B′ shows another example). (C) Effects of signaling agonists or antagonists on ectopic expression of Keratin or Six1 in the neural plate (NP). After Dlx3 mRNA injection, the increase in ectopic Six1 expression by dorsomorphin was blocked by the Wnt agonist azakenpaullone and the FGF antagonist SU5402, whereas co-injection of FGF8 had no significant effect. After GATA2 mRNA injection, dorsomorphin did not increase ectopic Six1 expression, whereas Keratin (not shown) was never ectopically expressed (Fisher’s exact test; *P≤0.05, n.s., not significant). (D-E′′) Transverse sections through neural plate of embryos shown in A (D-D′′) and the inset of B′ (E-E′′). Sections are shown in brightfield (D,E) in the green fluorescent channel, showing mycGFP-positive Dlx3-injected cells (D′,E′); in the red fluorescent channel, showing Sox3 immunostaining (D′,E′); and in overlay (D′′,E′′). DAPI-stained nuclei are shown for orientation in all panels. Ectopic Keratin and Six1 expression is confined to Dlx3-injected cells (asterisks), whereas residual Sox3 staining on injected side is found only in cells that did not receive Dlx3 (arrows). not, notochord.

Gene Clone Species Stages Anatomy
sox3.S laevis NF stage 18 pre-chordal neural plate , chordal neural plate , neural plate , neural plate border , anterior placodal area

Display additional annotations [+]
  Fig. S3. Effects of Dlx3 or GATA2 loss of function after injection of engrailed repressor constructs on neural and non-neural ectodermal markers. Neural plate stage embryos after unilateral injection (lower half; marked by light blue β-galactosidase or green mycGFP staining) of various constructs as indicated. Reductions (arrows), and broadening or ectopic expression domains (asterisks) in the neural (green) and non-neural ectoderm (orange) compared with the control side (arrowheads) are indicated. Double asterisks indicate lateral displacement owing to widening of the neural plate. See text for details.

Gene Clone Species Stages Anatomy
sox3.S laevis NF stage 20 pre-chordal neural plate , chordal neural plate , neural plate , anterior neural fold , anterior placodal area

Display additional annotations [+]
  Fig. 4. Effects of Dlx3 or GATA2 gain or loss of function on neural ectodermal markers. (A-G′′) Neural plate stage embryos after unilateral injection (lower half; marked by light blue β-galactosidase or green mycGFP staining) of various constructs as indicated. Reductions (arrows), and broadening or ectopic expression domains (asterisks) in the neural (green) and non-neural ectoderm (orange) compared with the control side (arrowheads) are indicated. Double asterisks indicate lateral displacement owing to widening of the neural plate. For Msx1, additional examples of embryos are shown in the insets in C and C′.

Gene Clone Species Stages Anatomy
sox3.S laevis NF stage 22 epibranchial placode , cranial placode , lateral line placode , neural tube , anterior placodal area

Display additional annotations [+]
  Fig. 1 . Induction of ectodermal markers at neural plate boundaries. Ectodermal marker expression in tailbud stage embryos (albino) that had received neural plate grafts (pigmented and/or mycGFP-labeled) into belly ectoderm at stage 13. (A-F′′) Grafts (arrows, outlined) are shown in overviews (A-F) and transverse sections in brightfield (A′-F′), green fluorescent channel (A′-F′), and overlay (A′′-F′′). Sox3 (A-A′′), Sox11 (B-B′′), Zic1 (C-C′′; inset shows higher magnification of expression in graft) and FoxD3 (D-D′′) are maintained or induced (asterisks) in graft. Six1 (F-F′′) is induced in host ectoderm (arrowheads), whereas Sox9 (E-E′′) is induced in the graft (asterisk) and sometimes in host ectoderm (arrowhead).